ArticleThe Lancet. Microbe2022

Searching for new therapeutic options for the uncommon pathogen Mycobacterium chimaera: an open drug discovery approach.

Daire Cantillon et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.